Dr. I-Chow "Joe" Hsu is an internationally recognized radiation oncologist with special expertises in brachytherapy and hyperthermia. Dr. Hsu’s research investigates the application of Hight Dose Rate (HDR) brachytherapy, a highly precise and conformal treatment that delivers radiotherapy by temporarily placing a minute radioactive source in the tumor using minimal invasive, image guided procedures.  His research in hyperthermia, a moderate temperature elevation (40-45° C) of the targeted tumor, explores the synergy between thermal therapy and radiotherapy to improve treatment efficacy without increasing treatment related toxicity.  His research in the treatment of genitourinary and gynecologic malignancies have lead to improved clinical outcomes and effective novel treatments for challenging clinical conditions. Dr. Hsu earned a medical degree at the Johns Hopkins School of Medicine. He is an active member of American Society for Radiation Oncology, American Brachytherapy Society and Society for Thermal Medicine.  He has been recognized as a Fellow of American College of Radiology and as a Fellow of American Society for Radiation Oncology.

Dr. Marjory Jolicoeur studied at Université de Montréal for a an MD, PhD degree.  She founded Curietherapies in 2012, a non-profit organization that she still presides over today. A renowned radiation oncologist, she completed her residency at Université de Montreal in 1996, before completing a brachytherapy fellowship at the Centre Georges-François Leclerc located in Dijon (France). In 1997, she started working at the department of Radiation Oncology of Université de Montréal, where she still teaches. A mere two years later, she was appointed medical consultant for all planning, construction and equipment selection processes of the new Radiation Oncology department of Hospital Charles-Le Moyne. She innovates by equipping the department with a suite and a comprehensive image-guided brachytherapy program. As a brachytherapy specialist, she has special research interests in its application to pathologies such as breast, genitourinary and gynecologic cancers. Her main focus is on the development of image guided implant procedures, the use of MRI in brachytherapy and the precision delivery of conformal high dose rate brachytherapy. She also teaches brachytherapy nationally and internationally.  She is also a recipient of the Jean Roy  Brachytherapy Award of 2021. 

Geetha Menon is a Senior Medical Physicist at the Cross Cancer Institute, Edmonton, AB and anAssociate Clinical Professor in the Department of Oncology, University of Alberta. She is a Fellow of theCanadian College of Physicists in Medicine (CCPM). Over the years, her clinical focus has been inbrachytherapy and women’s cancers. Her principal research interests are in gynecological, ocular, andprostate brachytherapy, which have resulted in many innovative research initiatives. She has been thelocal physics lead for the EMBRACE studies. In the last 10 years, she has received various grants andher multidisciplinary partnership has resulted in several peer-reviewed journal articles. She currentlyserves the Registrar on the CCPM Board. Dr. Menon is also an active member of the CanadianOrganization of Medical Physicists’ Women’s Committee and IDEA group.